Skip to content
Twitter Linkedin
  • +1 (854) 900-2020
  • info@xcelerate.global
  • ir@xcelerate.global
  • Home
  • Company
    • About Us
    • Leadership
    • A Moment with Mike…
  • Technology
    • Research & Development
    • Patent Acquisition
    • TeleHealth
    • Med-Tech
  • Investors
    • Financials
    • Press Release
  • Home
  • Company
    • About Us
    • Leadership
    • A Moment with Mike…
  • Technology
    • Research & Development
    • Patent Acquisition
    • TeleHealth
    • Med-Tech
  • Investors
    • Financials
    • Press Release
Contact US

Day: March 25, 2024

Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence

Mauldin, SC, Jan. 25, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC Pink: XCRT) today announced that it has filed a Supplemental Report with OTC Markets to remove the “shell’ status symbol from the OTC Markets webpage.“As a result of the Company’s recent Form 1-A filing with the SEC we believe that Xcelerate is no longer […]

Xcelerate Inc.

Transforming Breakthrough Engineering into Scalable Medical Solutions.

Twitter Linkedin

Contact

Xcelerate Inc.
110 renaissance Circle
Mauldin, SC29662

Phone
+1 864-228-2222

Email
info@xcelerate.global

Useful Links

  • Home
  • About Us
  • Bio
  • Technology
    • Research & Development
    • Patent Acquisition
    • Med-Tech
    • TeleHealth
  • A Moment with Mike…
  • Home
  • About Us
  • Bio
  • Technology
    • Research & Development
    • Patent Acquisition
    • Med-Tech
    • TeleHealth
  • A Moment with Mike…

Investor Links

  • Investors
  • Financials
  • Press Release
  • Investors
  • Financials
  • Press Release
  • 2026
  • XCELERATE INC.
  • All rights Reserved.